Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024. Summary of Results ? Fiscal...
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On June 12, 2024, Yield10 Bioscience, Inc. filed a Certificate of Amendment to its Amended...
Population growth or size is an essential component of economic development. A robust and vibrant population allows countries to allocate more labor to industrial and other economic activities.
/PRNewswire/ -- SN Bioscience Co., Ltd. (CEO Park Young-hwan) announced on May 24 that European Medicines Agency(EMA) had granted an orphan drug designation...
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 81,300 shares, an increase of 146.4% from the April 30th total of 33,000 shares. Approximately 2.2% of the company’s shares are short sold. […]